The University of Southampton
University of Southampton Institutional Repository

VEGF polymorphisms and severity of atherosclerosis

VEGF polymorphisms and severity of atherosclerosis
VEGF polymorphisms and severity of atherosclerosis
Introduction: Vascular endothelial growth factor (VEGF) is a potent angiogenic factor, and neovascularisation has been shown to be important in atherosclerotic plaque development. There is some disagreement as to whether VEGF acts as a pro-atherosclerotic or anti-atherosclerotic factor. In the present study we have sought to clarify this by determining genotypes and haplotypes for three reportedly functional VEGF SNPs in a large series of well documented coronary atherosclerosis patients.
Methods: VEGF –2578, –1154, and –634 single nucleotide polymorphisms were genotyped in 984 subjects from the Southampton Atherosclerosis Study, using the 5' nuclease assay for allelic discrimination (TaqMan).
Results: VEGF –2578 genotypes showed a significantly different distribution in patients without myocardial infarction when stratified according to number of diseased arteries. VEGF –2578 was also associated with mean number of stenotic segments in the same patient group. The AA genotype was a risk factor and CC was protective. These associations were significant before and after adjustment for classic risk factors, and were reflected in associations between VEGF haplotypes and the number of diseased arteries and stenotic segments. As VEGF –2578 CC has been provisionally shown to be associated with higher VEGF expression than the AA genotype, these results are consistent with a protective effect for VEGF in atherosclerosis development. Some changes in VEGF –1154 genotype frequencies were also detected, but no significant associations were detected for any one particular genotype.
Conclusions: This study provides preliminary evidence that VEGF polymorphism is associated with development of atherosclerosis, possibly via regulation of VEGF expression, supporting a protective effect for VEGF in atherosclerosis. These results require replication in an independent study group, combined with study of additional candidate polymorphisms in the VEGF gene.
vegf, angiogenesis, atherosclerosis
0022-2593
485-490
Howell, W.M.
dc6fe896-2230-4cf3-9862-f979cb872454
Ali, S.
4b1f46f4-584f-4b1f-a2d0-5443c23409c8
Rose-Zerilli, M.J.
5b58c2f6-62b2-4683-a777-cae95cdf1c62
Ye, S.
73027825-861c-4bca-8ce6-67a325fa2d2c
Howell, W.M.
dc6fe896-2230-4cf3-9862-f979cb872454
Ali, S.
4b1f46f4-584f-4b1f-a2d0-5443c23409c8
Rose-Zerilli, M.J.
5b58c2f6-62b2-4683-a777-cae95cdf1c62
Ye, S.
73027825-861c-4bca-8ce6-67a325fa2d2c

Howell, W.M., Ali, S., Rose-Zerilli, M.J. and Ye, S. (2005) VEGF polymorphisms and severity of atherosclerosis. Journal of Medical Genetics, 42 (6), 485-490. (doi:10.1136/jmg.2004.025734).

Record type: Article

Abstract

Introduction: Vascular endothelial growth factor (VEGF) is a potent angiogenic factor, and neovascularisation has been shown to be important in atherosclerotic plaque development. There is some disagreement as to whether VEGF acts as a pro-atherosclerotic or anti-atherosclerotic factor. In the present study we have sought to clarify this by determining genotypes and haplotypes for three reportedly functional VEGF SNPs in a large series of well documented coronary atherosclerosis patients.
Methods: VEGF –2578, –1154, and –634 single nucleotide polymorphisms were genotyped in 984 subjects from the Southampton Atherosclerosis Study, using the 5' nuclease assay for allelic discrimination (TaqMan).
Results: VEGF –2578 genotypes showed a significantly different distribution in patients without myocardial infarction when stratified according to number of diseased arteries. VEGF –2578 was also associated with mean number of stenotic segments in the same patient group. The AA genotype was a risk factor and CC was protective. These associations were significant before and after adjustment for classic risk factors, and were reflected in associations between VEGF haplotypes and the number of diseased arteries and stenotic segments. As VEGF –2578 CC has been provisionally shown to be associated with higher VEGF expression than the AA genotype, these results are consistent with a protective effect for VEGF in atherosclerosis development. Some changes in VEGF –1154 genotype frequencies were also detected, but no significant associations were detected for any one particular genotype.
Conclusions: This study provides preliminary evidence that VEGF polymorphism is associated with development of atherosclerosis, possibly via regulation of VEGF expression, supporting a protective effect for VEGF in atherosclerosis. These results require replication in an independent study group, combined with study of additional candidate polymorphisms in the VEGF gene.

This record has no associated files available for download.

More information

Published date: 2005
Keywords: vegf, angiogenesis, atherosclerosis

Identifiers

Local EPrints ID: 24772
URI: http://eprints.soton.ac.uk/id/eprint/24772
ISSN: 0022-2593
PURE UUID: cd6d0230-0ddb-4cea-a8d4-a7d73658a009

Catalogue record

Date deposited: 03 Apr 2006
Last modified: 15 Mar 2024 06:58

Export record

Altmetrics

Contributors

Author: W.M. Howell
Author: S. Ali
Author: M.J. Rose-Zerilli
Author: S. Ye

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×